Abstract
Background
For patients with pancreatic tumors, several disparities have been shown to impact access to care, including surgery, and subsequently adversely affect long-term oncologic outcomes. The aim of this study was to investigate national disparities in minimally invasive surgery (MIS) across different demographics for pancreatic tumors.
Methods
We utilized the American College of Surgeons (ACS) National Cancer Data Base (NCDB) to identify patients with pancreatic tumors from 2010 to 2011 who had undergone surgery through either an open or MIS approach. Multivariable analysis was performed to investigate differences in patient characteristics in relation to surgical approach and conversion to open.
Results
A total of 2809 patients were identified. The initial surgical approach included 86.5 % open (2430) and 13.5 % MIS (87.6 % were laparoscopic, and 12.4 % were robotic). Tumor histology was significantly associated with MIS, whereby patients with neuroendocrine tumors were more than twice as likely to have an MIS approach compared to adenocarcinoma. Tumor location within the pancreas was also associated with MIS, with tumors in the tail being three times more likely to be removed through MIS compared to tumors in the head. For patients with disease in the body or tail of the pancreas, ethnicity was independently associated with MIS whereby patients of Hispanic origin were less likely to have MIS. The conversion rate to open was 27.7 %, and geographic location was associated with conversion rates.
Conclusions
MIS procedures comprise approximately 13.5 % of surgical procedures for pancreatic tumors. In addition to tumor histology, differences in surgical approach were identified with respect to ethnicity for patients with tumors in the body/tail of the pancreas.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29
Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241
Oettle H, Neuhaus P, Hochhaus A et al (2013) Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA 310:1473–1481
Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov). SEER Stat Fact Sheets: Breast Cancer. http://seer.cancer.gov/statfacts/html/breast.html. Accessed 5 May 2015
Klimstra DS (2007) Nonductal neoplasms of the pancreas. Mod Pathol 20(Suppl 1):S94–S112
de Jong K, Bruno MJ, Fockens P (2012) Epidemiology, diagnosis, and management of cystic lesions of the pancreas. Gastroenterol Res Pract 2012:147465
Dickson PV, Behrman SW (2013) Management of pancreatic neuroendocrine tumors. Surg Clin North Am 93:675–691
Stauffer JA, Asbun HJ (2015) Minimally invasive pancreatic surgery. Semin Oncol 42:123–133
Place TL, Nau P, Mezhir JJ (2015) Minimally invasive pancreatectomy for cancer: a critical review of the current literature. J Gastrointest Surg 19:375–386
Fernandez-Cruz L, Blanco L, Cosa R, Rendon H (2008) Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg 32:904–917
Al-Kurd A, Chapchay K, Grozinsky-Glasberg S, Mazeh H (2014) Laparoscopic resection of pancreatic neuroendocrine tumors. World J Gastroenterol 20:4908–4916
National Comprehensive Cancer Network. Hepatobiliary Cancers. (Version 4.2014). http://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf. Accessed 5 Nov
Krzyzanowska MK, Weeks JC, Earle CC (2003) Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol 21:3409–3414
Shapiro M, Chen Q, Huang Q et al (2016) Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer. JAMA Surg 151:338–345
Amin S, Lucas AL, Frucht H (2013) Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Pancreas 42:249–253
Barbas AS, Turley RS, Ceppa EP et al (2012) Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. J Am Geriatr Soc 60:344–350
Khawja SN, Mohammed S, Silberfein EJ et al (2015) Pancreatic cancer disparities in african americans. Pancreas 44:522–527
Shah A, Chao KS, Ostbye T et al (2013) Trends in racial disparities in pancreatic cancer surgery. J Gastrointest Surg 17:1897–1906
Singal V, Singal AK, Kuo YF (2012) Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol 138:715–722
Abraham A, Al-Refaie WB, Parsons HM et al (2013) Disparities in pancreas cancer care. Ann Surg Oncol 20:2078–2087
Riall TS, Townsend CM Jr, Kuo YF et al (2010) Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer 116:930–939
Murphy MM, Simons JP, Hill JS et al (2009) Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma. Cancer 115:3979–3990
Murphy MM, Simons JP, Ng SC et al (2009) Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol 16:2968–2977
Shaib Y, Davila J, Naumann C, El-Serag H (2007) The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol 102:1377–1382
Seyedin S, Luu C, Stabile BE, Lee B (2012) Effect of socioeconomic status on surgery for pancreatic adenocarcinoma. Am Surg 78:1128–1131
Cheung MC, Yang R, Byrne MM et al (2010) Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma? Cancer 116:723–733
Zell JA, Rhee JM, Ziogas A et al (2007) Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev 16:546–552
Helling TS (2010) Pancreas cancer in Mississippi: present challenges and future directions. J Miss State Med Assoc 51:99–103
Riall TS, Eschbach KA, Townsend CM Jr et al (2007) Trends and disparities in regionalization of pancreatic resection. J Gastrointest Surg 11:1242–1251 (discussion 1251–1242)
American Joint Committee on Cancer (2002) Manual for Staging of Cancer, 6th edn. Lippincott Raven Publishers, Philadelphia
Kooby DA, Gillespie T, Bentrem D et al (2008) Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg 248:438–446
Abu Hilal M, Hamdan M, Di Fabio F et al (2012) Laparoscopic versus open distal pancreatectomy: a clinical and cost-effectiveness study. Surg Endosc 26:1670–1674
Zureikat AH, Moser AJ, Boone BA et al (2013) 250 robotic pancreatic resections: safety and feasibility. Ann Surg 258:554–559 discussion 559–562
Chen S, Chen JZ, Zhan Q et al (2015) Robot-assisted laparoscopic versus open pancreaticoduodenectomy: a prospective, matched, mid-term follow-up study. Surg Endosc 29:3698–3711
Jin T, Altaf K, Xiong JJ et al (2012) A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy. HPB (Oxford) 14:711–724
Guerra F, Pesi B, Amore Bonapasta S et al (2015) Challenges in robotic distal pancreatectomy. Systematic review of current practice. Minerva Chir 70:241–247
Joyce D, Morris-Stiff G, Falk GA et al (2014) Robotic surgery of the pancreas. World J Gastroenterol 20:14726–14732
Daouadi M, Zureikat AH, Zenati MS et al (2013) Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg 257:128–132
Waters JA, Canal DF, Wiebke EA et al (2010) Robotic distal pancreatectomy: cost effective? Surgery 148:814–823
Kim CW, Kim CH, Baik SH (2014) Outcomes of robotic-assisted colorectal surgery compared with laparoscopic and open surgery: a systematic review. J Gastrointest Surg 18:816–830
Fernandez-Cruz L, Martinez I, Cesar-Borges G et al (2005) Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1. J Gastrointest Surg 9:381–388
Fernandez-Cruz L, Herrera M, Saenz A et al (2001) Laparoscopic pancreatic surgery in patients with neuroendocrine tumours: indications and limits. Best Pract Res Clin Endocrinol Metab 15:161–175
Niederhuber JE, Brennan MF, Menck HR (1995) The National Cancer Data Base report on pancreatic cancer. Cancer 76:1671–1677
Bilimoria KY, Bentrem DJ, Ko CY et al (2007) National failure to operate on early stage pancreatic cancer. Ann Surg 246:173–180
Polite BN, Sing A, Sargent DJ et al (2012) Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE). Cancer 118:1083–1090
Polite BN, Dignam JJ, Olopade OI (2005) Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. Med Clin North Am 89:771–793
Navez B, Navez J (2014) Laparoscopy in the acute abdomen. Best Pract Res Clin Gastroenterol 28:3–17
Acknowledgments
We thank the Commission on Cancer of the American College of Surgeons and American Cancer Society for access to the NCDB Participant User File.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. Gabriel, Dr. Thirunavukarasu, Dr. Attwood and Dr. Nurkin have no conflicts of interest or financial ties to disclose.
Additional information
Disclaimers The American College of Surgeons Committee on Cancer provided the Participant User File from the National Cancer Data Base, but has not reviewed or validated the results or conclusions of our study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gabriel, E., Thirunavukarasu, P., Attwood, K. et al. National disparities in minimally invasive surgery for pancreatic tumors. Surg Endosc 31, 398–409 (2017). https://doi.org/10.1007/s00464-016-4987-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-016-4987-6